# BRGX (Bioregenx, Inc.) - SEC EDGAR Financial Statements

> Bioregenx, Inc. reported $1.77M in revenue and a net loss of $1.30M for the trailing twelve months ended March 31, 2026 (down 17.3% year over year), with a 81.9% gross margin and a -62.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/BRGX
- Markdown: https://convexityos.com/fundamentals/BRGX.md
- SEC CIK: 0001593184
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001593184&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.77M | -17.3% YoY |
| Operating Income | TTM | -$1.10M | -62.4% margin |
| Net Income | TTM | -$1.30M | -73.8% net margin |
| Diluted EPS | TTM | -$0.00 | Split-adjusted |
| Free Cash Flow | TTM | $30K | 1.7% FCF margin |
| Cash & ST Investments | Mar 31, 2026 | $46K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.85M | $2.34M | $3.41M | $42K | $199K |
| Cost of Revenue | $351K | $682K | $1.10M | $0 | $554 |
| **Gross Profit** | $1.50M | $1.66M | $2.31M | $42K | $198K |
| Research & Development | $32K | $0 | $258K | -- | -- |
| Selling, General & Admin | $2.01M | $5.85M | $5.23M | -- | -- |
| Total Operating Expenses | $2.75M | $24.42M | $5.72M | $120K | $363K |
| **Operating Income** | -$1.24M | -$22.76M | -$3.41M | -$78K | -$165K |
| **EBITDA** | -$1.17M | -$20.54M | -$3.40M | -- | -- |
| Interest Expense | $300K | $291K | $292K | $0 | -- |
| Income Before Tax | -- | -- | -$571K | -$78K | -$97K |
| Income Tax Expense | -- | -- | $0 | $0 | $0 |
| **Net Income** | -$1.54M | -$23.05M | -$3.60M | -$78K | -$97K |
| Basic EPS | $0.00 | -$0.03 | -$0.01 | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | -$0.03 | -$0.01 | $0.00 | $0.00 |
| Basic Shares Outstanding | 959.7M | 912.4M | 639.8M | 269.7M | 269.7M |
| Diluted Shares Outstanding | 959.7M | 912.4M | 639.8M | 269.7M | 269.7M |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $426K | $386K | $508K | $446K | $515K | $460K | $596K | $734K |
| Cost of Revenue | $78K | $67K | $81K | $94K | $109K | $138K | $114K | $264K |
| **Gross Profit** | $348K | $319K | $426K | $352K | $406K | $323K | $482K | $470K |
| Research & Development | -- | $32K | $0 | $0 | $0 | -$15K | $0 | $7.5K |
| Selling, General & Admin | $396K | $552K | $433K | $457K | $590K | $1.87M | $236K | $1.40M |
| Total Operating Expenses | $398K | $1.25M | $435K | $460K | $599K | $18.64M | $809K | $1.51M |
| **Operating Income** | -$50K | -$936K | -$8.5K | -$107K | -$193K | -$18.32M | -$327K | -$1.04M |
| **EBITDA** | -$37K | -- | $3.9K | -$70K | -$180K | -$17.74M | -$315K | -$1.03M |
| Interest Expense | $77K | $82K | $72K | $71K | $74K | $3.7K | $68K | $66K |
| **Net Income** | -$26K | -$1.02M | -$81K | -$178K | -$267K | -$18.40M | -$395K | -$1.11M |
| Basic EPS | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 |
| Basic Shares Outstanding | 969.2M | -- | 960.9M | 959.2M | 957.0M | -- | 956.5M | 956.5M |
| Diluted Shares Outstanding | 969.2M | -- | 960.9M | 959.2M | 957.0M | -- | 956.5M | 956.5M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $69K | $58K | $125K | $676 | $24K |
| **Cash & Short-Term Investments** | $69K | $58K | $125K | $676 | $24K |
| Accounts Receivable, Net | $40K | $15K | $105K | -- | -- |
| Inventory | $107K | $111K | $218K | -- | -- |
| Other Current Assets | $30K | $118K | $143K | -- | -- |
| **Total Current Assets** | $251K | $308K | $653K | $676 | $24K |
| Property, Plant & Equipment, Net | $160K | $201K | $14K | -- | -- |
| Goodwill | -- | -- | $0 | -- | -- |
| Intangible Assets | -- | $0 | $49K | $37K | $43K |
| Other Non-Current Assets | -- | $0 | $150K | -- | -- |
| **Total Non-Current Assets** | $160K | $201K | $32K | $58K | $103K |
| **Total Assets** | $411K | $509K | $866K | $59K | $128K |
| Accounts Payable | $616K | $427K | $242K | -- | -- |
| Short-Term Debt | $1.00M | $883K | $200K | $4.2K | $2.2K |
| Deferred Revenue (Current) | $60K | $197K | $354K | -- | -- |
| **Total Current Liabilities** | $4.07M | $3.63M | $2.79M | $65K | $14K |
| Long-Term Debt | $182K | $255K | $0 | $196K | $198K |
| **Total Non-Current Liabilities** | $882K | $255K | $150K | $196K | $198K |
| **Total Liabilities** | $4.95M | $3.89M | $2.94M | $261K | $212K |
| **Total Debt (incl. Leases)** | $1.19M | $1.14M | $200K | $200K | $200K |
| Common Stock | $969K | $957K | $771K | $270K | $270K |
| Retained Earnings | -$37.12M | -$35.57M | -$12.52M | -$2.92M | -$2.80M |
| Accumulated Other Comp. Income | $0 | $2.0K | -$942 | -- | -- |
| **Total Stockholders' Equity** | -$4.54M | -$3.38M | -$2.07M | -$2.53M | -$84K |
| Total Equity | -$4.54M | -$3.38M | -$2.07M | -$2.53M | -$84K |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $46K | $69K | $47K | $46K | $84K | $58K | $70K | $57K |
| **Cash & Short-Term Investments** | $46K | $69K | $47K | $46K | $84K | $58K | $70K | $57K |
| Accounts Receivable, Net | $18K | $40K | $63K | $21K | $11K | $15K | $19K | $11K |
| Inventory | $93K | $107K | $109K | $134K | $140K | $111K | $159K | $144K |
| Other Current Assets | $28K | $30K | $49K | $43K | $54K | $118K | $73K | $109K |
| **Total Current Assets** | $190K | $251K | $273K | $250K | $294K | $308K | $371K | $326K |
| Property, Plant & Equipment, Net | $147K | $160K | $170K | $176K | $188K | $201K | $213K | $225K |
| Goodwill | -- | -- | -- | -- | -- | -- | $7.11M | $7.11M |
| Intangible Assets | -- | -- | $725K | $725K | -- | $0 | $9.67M | $10.23M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Total Non-Current Assets** | $147K | $160K | $895K | $901K | $188K | $201K | $16.99M | $17.56M |
| **Total Assets** | $337K | $411K | $1.17M | $1.15M | $483K | $509K | $17.36M | $17.89M |
| Accounts Payable | $699K | $616K | $460K | $569K | $491K | $427K | $493K | $432K |
| Short-Term Debt | -- | $1.00M | -- | -- | -- | $883K | -- | -- |
| Deferred Revenue (Current) | $57K | $60K | $96K | $125K | $189K | $197K | $166K | $196K |
| **Total Current Liabilities** | $3.99M | $4.07M | $3.93M | $3.93M | $3.78M | $3.63M | $3.52M | $3.42M |
| Long-Term Debt | -- | $182K | -- | -- | -- | $255K | -- | -- |
| **Total Non-Current Liabilities** | $883K | $882K | $881K | $880K | $257K | $255K | $282K | $250K |
| **Total Liabilities** | $4.87M | $4.95M | $4.81M | $4.81M | $4.04M | $3.89M | $3.80M | $3.67M |
| **Total Debt (incl. Leases)** | -- | $1.19M | -- | -- | -- | $1.14M | -- | -- |
| Common Stock | $972K | $969K | $962K | $961K | $960K | $957K | $957K | $957K |
| Retained Earnings | -$37.14M | -$37.12M | -$36.10M | -$36.02M | -$35.84M | -$35.57M | -$17.17M | -$16.78M |
| Accumulated Other Comp. Income | -- | $0 | -- | -$7.2K | -$25 | $2.0K | -$1.9K | $618 |
| **Total Stockholders' Equity** | -$4.53M | -$4.54M | -$3.65M | -$3.65M | -$3.56M | -$3.38M | $13.56M | $14.22M |
| Total Equity | -$4.53M | -$4.54M | -$3.65M | -$3.65M | -$3.56M | -$3.38M | $13.56M | $14.22M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$1.54M | -$23.05M | -$3.60M | -$78K | -$97K |
| Depreciation & Amortization | $75K | $2.22M | $4.8K | -- | -- |
| Stock-Based Compensation | $0 | $2.85M | $2.24M | -- | -- |
| Change in Receivables | -$25K | $90K | -$21K | $0 | $971 |
| Change in Inventory | $4.2K | $106K | -$36K | -- | -- |
| **Operating Cash Flow** | $39K | -$324K | -$1.52M | -$65K | -$120K |
| Capital Expenditure | -$9.1K | -$189K | $0 | -- | -- |
| **Free Cash Flow** | $30K | -$514K | -$1.52M | -- | -- |
| **Investing Cash Flow** | -$59K | -$188K | -$199K | $0 | $0 |
| Common Stock Issued | -- | $0 | $1.34M | -- | -- |
| **Financing Cash Flow** | $33K | $442K | $1.20M | $41K | $50K |
| **Net Change in Cash** | $11K | -$67K | -$491K | -$24K | -$70K |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26K | -$1.02M | -$81K | -$178K | -$267K | -$18.40M | -$395K | -$1.11M |
| Depreciation & Amortization | $13K | -- | $12K | $37K | $12K | $574K | $12K | $7.6K |
| Stock-Based Compensation | $6.8K | $0 | $0 | $0 | $0 | $1.36M | -$331K | $173K |
| Change in Receivables | $21K | $23K | -$41K | -$10.0K | $3.8K | $4.5K | -$8.5K | $232 |
| Change in Inventory | $14K | $2.4K | $25K | $6.2K | -$29K | $48K | -$15K | $69K |
| **Operating Cash Flow** | $27K | $70K | -$72K | $3.2K | $38K | -$11K | -$31K | -$177K |
| Capital Expenditure | -- | -$3.1K | -$6.0K | $0 | $0 | $0 | $0 | $0 |
| **Free Cash Flow** | -- | $67K | -$78K | $3.2K | $38K | -$11K | -$31K | -$177K |
| **Investing Cash Flow** | -- | -$3.1K | -$6.0K | -$50K | $0 | $2.7K | $0 | $0 |
| **Financing Cash Flow** | -$50K | -$44K | $71K | $17K | -$10K | -$6.9K | $46K | $120K |
| **Net Change in Cash** | -$24K | $22K | $491 | -$37K | $25K | -$12K | $13K | -$57K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 81.1% | 70.9% | 67.8% | 100.0% | 99.7% |
| **Operating Margin** | -67.1% | -972.7% | -99.9% | -185.7% | -83.1% |
| **Net Profit Margin** | -83.2% | -985.2% | -105.5% | -185.7% | -48.8% |
| Return on Assets (ROA) | -375.6% | -4533.4% | -415.8% | -132.4% | -75.8% |
| Current Ratio | 0.06x | 0.08x | 0.23x | 0.01x | 1.72x |
| Quick Ratio | 0.04x | 0.05x | 0.16x | 0.01x | 1.72x |
| **Revenue Growth (YoY)** | -20.8% | -31.4% | +7991.8% | -78.8% | -- |
| Gross Profit Growth (YoY) | -9.3% | -28.3% | +5382.6% | -78.7% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 81.9% | 81.1% | 78.1% | 77.5% | 72.9% | 70.9% | -- | -- |
| **Operating Margin** | -62.4% | -67.1% | -965.4% | -938.9% | -862.1% | -972.7% | -182.1% | -246.7% |
| **Net Profit Margin** | -73.8% | -83.2% | -981.0% | -953.6% | -874.7% | -985.2% | -192.0% | -255.2% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -36.2% | -49.5% |
| Return on Assets (ROA) | -386.6% | -375.6% | -1620.7% | -1672.3% | -4178.9% | -4533.4% | -28.3% | -39.3% |
| Current Ratio | 0.05x | 0.06x | 0.07x | 0.06x | 0.08x | 0.08x | 0.11x | 0.10x |
| Quick Ratio | 0.02x | 0.04x | 0.04x | 0.03x | 0.04x | 0.05x | 0.06x | 0.05x |
| **Revenue Growth (YoY)** | -17.3% | -16.3% | -14.8% | -39.2% | -6.3% | -32.1% | -25.0% | -15.0% |
| Gross Profit Growth (YoY) | -14.2% | -1.2% | -11.5% | -25.0% | +5.7% | -- | -15.7% | -21.5% |
| Operating Cash Flow Growth (YoY) | -29.4% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
